Drug Pricing Shake Up Likely In Germany
Top Pricing And Reimbursement Authority Wants To Slash Free Pricing Period
The umbrella organization for public insurers is also expected to publish its own suggestions on how to cut spending on pharmaceuticals, including interim prices for conditionally approved drugs.
You may also be interested in...
The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.
Draft proposals to improve EU-wide cooperation on health technology assessments, including mandatory joint clinical assessments, have won support from EFPIA, the European Federation of Pharmaceutical Industries and Associations.
Big changes are in store on the drug pricing front in Germany. Further reforms could depend on who is appointed health minister.